Evidence map›Paper›PMID 27480115›Full record

ArticleBMC biology2016

On the reversibility of parasitism: adaptation to a free-living lifestyle via gene acquisitions in the diplomonad Trepomonas sp. PC1.

Feifei Xu, Jon Jerlström-Hultqvist, Martin Kolisko, Alastair G B Simpson, Andrew J Roger, Staffan G Svärd, Jan O Andersson

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 76 citations in OpenAlex.

  1. Loss, persistence and reversal of phenotypic traits.Biological reviews of the Cambridge Philosophical Society · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Transcriptome data sets of free-living diplomonads,Microbiology resource announcements · 2023
    Article
  9. Article
  10. Article
  11. Human follicular mites: Ectoparasites becoming symbionts.Molecular biology and evolution · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Feifei XuDepartment of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Jon Jerlström-HultqvistDepartment of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Martin KoliskoDepartment of Biology, Dalhousie University, Halifax, NS, Canada.
Alastair G B SimpsonDepartment of Biology, Dalhousie University, Halifax, NS, Canada.
Andrew J RogerDepartment of Biochemistry and Molecular Biology, Dalhousie University, Halifax, NS, Canada.
Staffan G SvärdDepartment of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Jan O AnderssonDepartment of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. jan.andersson@icm.uu.se.
Uppsala University · SEDalhousie University · CACanadian Institute for Advanced Research · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is generally thought that the evolutionary transition to parasitism is irreversible because it is associated with the loss of functions needed for a free-living lifestyle. Nevertheless, free-living taxa are sometimes nested within parasite clades in phylogenetic trees, which could indicate that they are secondarily free-living. Herein, we test this hypothesis by studying the genomic basis for evolutionary transitions between lifestyles in diplomonads, a group of anaerobic eukaryotes. Most described diplomonads are intestinal parasites or commensals of various animals, but there are also free-living diplomonads found in oxygen-poor environments such as marine and freshwater sediments. All these nest well within groups of parasitic diplomonads in phylogenetic trees, suggesting that they could be secondarily free-living.

resultsWe present a transcriptome study of Trepomonas sp. PC1, a diplomonad isolated from marine sediment. Analysis of the metabolic genes revealed a number of proteins involved in degradation of the bacterial membrane and cell wall, as well as an extended set of enzymes involved in carbohydrate degradation and nucleotide metabolism. Phylogenetic analyses showed that most of the differences in metabolic capacity between free-living Trepomonas and the parasitic diplomonads are due to recent acquisitions of bacterial genes via gene transfer. Interestingly, one of the acquired genes encodes a ribonucleotide reductase, which frees Trepomonas from the need to scavenge deoxyribonucleosides. The transcriptome included a gene encoding squalene-tetrahymanol cyclase. This enzyme synthesizes the sterol substitute tetrahymanol in the absence of oxygen, potentially allowing Trepomonas to thrive under anaerobic conditions as a free-living bacterivore, without depending on sterols from other eukaryotes.

conclusionsOur findings are consistent with the phylogenetic evidence that the last common ancestor of diplomonads was dependent on a host and that Trepomonas has adapted secondarily to a free-living lifestyle. We believe that similar studies of other groups where free-living taxa are nested within parasites could reveal more examples of secondarily free-living eukaryotes.

Indexed as

Genes, ProtozoanAdaptation, PhysiologicalAnimalsCell WallDiplomonadidaIntramolecular TransferasesLikelihood FunctionsLysosomesParasitesPhylogenyTranscriptomeIntramolecular Transferasessqualene-hopene cyclaseDiplomonadDollo’s lawFree-livingHorizontal gene transferParasiteReversibilityRibonucleotide reductaseTrepomonas

Identifiers

PMID27480115
PMCPMC4967989
OpenAlexW2477505313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.